Sector
HealthcareOpen
₹504Prev. Close
₹507.7Turnover(Lac.)
₹50.4Day's High
₹515.65Day's Low
₹499.3552 Week's High
₹623.1552 Week's Low
₹390.3Book Value
₹147.91Face Value
₹2Mkt Cap (₹ Cr.)
1,140.34P/E
29EPS
17.51Divi. Yield
0.3918 May 2024
12:00 AM
AGM
Announcement Date: 18 May, 2024
24 Jun 2024
12:00 AM
BookCloser
11 Jul 2024
12:00 AM
Board Meeting
Agenda : Audited Result
18 May 2024
12:00 AM
Dividend
Dividend Amount: 2
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 4.43 | 4.43 | 4.42 | 4.42 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 311.86 | 276.16 | 229.23 | 189.9 |
Net Worth | 316.29 | 280.59 | 233.65 | 194.32 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 275.98 | 209.05 | 180.67 | 181.09 |
yoy growth (%) | 32.01 | 15.7 | -0.23 | 17.7 |
Raw materials | -78.72 | -60.84 | -53.74 | -50.26 |
As % of sales | 28.52 | 29.1 | 29.74 | 27.75 |
Employee costs | -75.41 | -60.25 | -61.42 | -53.64 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 56.57 | 28.39 | 8.34 | 25.56 |
Depreciation | -23.15 | -22.93 | -20.92 | -15.7 |
Tax paid | -14.29 | -7.13 | -1.41 | -9.13 |
Working capital | 10.67 | 6.67 | 12.17 | 18.35 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 32.01 | 15.7 | -0.23 | 17.7 |
Op profit growth | 51.39 | 75.54 | -33.69 | 65.74 |
EBIT growth | 89.98 | 152.36 | -60.63 | 65.2 |
Net profit growth | 93.12 | 206.91 | -57.84 | 55.14 |
| Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
|---|---|---|---|---|---|
Gross Sales | 318.26 | 318.19 | 278.28 | 210.68 | 180.71 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 318.26 | 318.19 | 278.28 | 210.68 | 180.71 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 4.01 | 3.44 | 1.45 | 0.83 | 3.02 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 6,381.95 | 90.85 | 91,806.5 | 238.8 | 0.09 | 1,894.6 | 536.28 |
Max Healthcare Institute Ltd MAXHEALTH | 920.45 | 130.13 | 89,420.8 | 241.77 | 0.16 | 610.11 | 79.02 |
Fortis Healthcare Ltd FORTIS | 481.4 | 293.17 | 36,298.39 | 68.33 | 0.21 | 307.48 | 120.36 |
Global Health Ltd MEDANTA | 1,204.3 | 89.61 | 32,288.01 | 92.24 | 0 | 578.65 | 106.09 |
Narayana Hrudayalaya Ltd NH | 1,242.45 | 59.8 | 25,381.61 | 158.09 | 0.32 | 846.31 | 90.04 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Executive Chairman
S P Vasireddi
Director (Operation)
V Harriman
Managing Director
Harita Vasireddi
Non-Exec. & Independent Dir.
Y Prameela Rani
Company Sec. & Compli. Officer
Sujani Vasireddi
Non-Exec. & Independent Dir.
G Purnachandra Rao
Non-Exec. & Independent Dir.
Sanjay Dave
Executive Director
Satya Sreenivas Neerukonda
Non-Exec. & Independent Dir.
Yadagiri R Pendri
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Vimta Labs Ltd
Summary
Vimta Labs Ltd., established in 1984, is Indias most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries. Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas of preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc. The Company was awarded ISO 9002 Certification under ISO/IEC Guide-25 as Certified Competent Laboratory and Quality Endorsed Company by Standards Australia Quality Assurance Services Pty. Ltd in 1994.In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial. The main essence of this Joint
Read More
What is the Vimta Labs Ltd share price today?
The Vimta Labs Ltd shares price on N/A is Rs.₹517.55 today.
What is the Market Cap of Vimta Labs Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vimta Labs Ltd is ₹1147.44 Cr. as of 22 Jul ‘24
What is the PE and PB ratio of Vimta Labs Ltd?
The PE and PB ratios of Vimta Labs Ltd is 29 and 3.56 as of 22 Jul ‘24
What is the 52 Week High and Low of Vimta Labs Ltd?
The 52-week high/low is the highest and lowest price at which a Vimta Labs Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vimta Labs Ltd is ₹390.6 and ₹621.4 as of 22 Jul ‘24
What is the CAGR of Vimta Labs Ltd?
Vimta Labs Ltd's CAGR for 5 Years at 28.64%, 3 Years at 19.00%, 1 Year at 9.81%, 6 Month at 16.71%, 3 Month at 13.07% and 1 Month at 3.32%.
What is the shareholding pattern of Vimta Labs Ltd?
The shareholding pattern of Vimta Labs Ltd is as follows:
Promoters - 36.89 %
Institutions - 6.65 %
Public - 56.46 %
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
